A case of cerebrotendinous xanthomatosis, incidence 1 in 50,000 [94], and catatonia was effectively treated with the specific treatment of chenodeoxycholic acid and HMG-CoA reductase inhibitor coupled with valproate for seizure control [95]. Here, HMGCR is linked to cerebrotendinous xanthomatosis.